Taipei, Taiwan

Wan-Jiun Chen

USPTO Granted Patents = 4 


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovations of Wan-Jiun Chen: Pioneering Cancer Research in Taipei

Introduction: Wan-Jiun Chen is a prominent inventor based in Taipei, Taiwan, recognized for his significant contributions to the field of cancer research. With a total of four patents to his name, his work primarily focuses on the identification and treatment of cancer stem cells, which play a critical role in cancer progression and recurrence.

Latest Patents: Among Wan-Jiun Chen's recent innovations, two noteworthy patents stand out. The first patent involves "Biomarkers for Lung Cancer Stem Cells." This invention offers methods and kits for analyzing biological samples from individuals diagnosed with or at risk of lung cancer, helping to determine the presence of cancer stem cells, which are indicative of poor cancer prognosis. The second patent, titled "Method for Treating Cancer Using CD14 Antagonists," outlines innovative methods for utilizing CD14 antagonists, including anti-CD14 antibodies, to treat cancer and reduce the stemness of cancer stem cells in patients.

Career Highlights: Wan-Jiun Chen is affiliated with the National Taiwan University, where he has advanced his research in oncology and stem cell biology. His academic background and dedication to innovative cancer therapies place him at the forefront of his field, contributing to groundbreaking discoveries.

Collaborations: Throughout his career, Wan-Jiun Chen has collaborated with esteemed colleagues, including Huei-Wen Chen and Pan-Chyr Yang. These partnerships foster a dynamic research environment, facilitating the exchange of ideas that drive innovation in cancer treatment.

Conclusion: Wan-Jiun Chen's contributions to cancer research exemplify the impact of innovative thinking and dedication to advancing medical science. His patents offer promising avenues for improving cancer prognosis and treatment, reflecting his commitment to enhancing patient outcomes. As he continues to develop pivotal technologies, Wan-Jiun Chen remains a significant figure in the landscape of cancer innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…